A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Arbutamine
Hydroxyprogesterone caproate
The risk or severity of adverse effects can be increased when Hydroxyprogesterone caproate is combined with Flibanserin.
Arbutamine
Gestodene
The risk or severity of adverse effects can be increased when Gestodene is combined with Flibanserin.
Arbutamine
Norelgestromin
The risk or severity of adverse effects can be increased when Norelgestromin is combined with Flibanserin.
Arbutamine
Lonidamine
The risk or severity of adverse effects can be increased when Lonidamine is combined with Flibanserin.
Arbutamine
Trestolone
The risk or severity of adverse effects can be increased when Trestolone is combined with Flibanserin.
Arbutamine
Cyproterone acetate
The risk or severity of adverse effects can be increased when Cyproterone acetate is combined with Flibanserin.
Arbutamine
Octylphenoxy polyethoxyethanol
The risk or severity of adverse effects can be increased when Octylphenoxy polyethoxyethanol is combined with Flibanserin.
Arbutamine
p-Coumaric acid
The risk or severity of adverse effects can be increased when p-Coumaric acid is combined with Flibanserin.
Arbutamine
Drospirenone
The risk or severity of adverse effects can be increased when Drospirenone is combined with Flibanserin.
Arbutamine
Mestranol
The risk or severity of adverse effects can be increased when Mestranol is combined with Flibanserin.
Arbutamine
Zopiclone
The risk or severity of adverse effects can be increased when Flibanserin is combined with Zopiclone.
Arbutamine
Chlorphenoxamine
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.
Arbutamine
Fesoterodine
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Arbutamine
Timepidium
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Timepidium.
Arbutamine
Pipenzolate
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.
Arbutamine
Emetonium iodide
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Emetonium iodide.
Arbutamine
Fenpiverinium
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Fenpiverinium.
Arbutamine
Camylofin
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Camylofin.
Arbutamine
Diphemanil
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.
Arbutamine
Penthienate
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Penthienate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3